People

Ali Fattaey
Myrobalan board adviser and biotechnology executive. Previously president and CEO of Curis and ACT Biotech, chief scientific officer at Sagres Discovery and a vice president at Onyx Pharmaceuticals. Holds a Kansas State University microbiology PhD.
Roles
Myrobalan Therapeutics
CurrentBoard Advisor